Exempt Chemical Preparations Under the Controlled Substances Act
The applications for exempt chemical preparations received by the Drug Enforcement Administration (DEA) between August 30, 2021, and March 31, 2022, as listed below, were accept...
Drug Enforcement Administration, Department of Justice.
ACTION:
Order with opportunity for comment.
SUMMARY:
The applications for exempt chemical preparations received by the Drug Enforcement Administration (DEA) between August 30, 2021, and March 31, 2022, as listed below, were accepted for filing and have been approved or denied as indicated.
DATES:
Interested persons may file written comments on this order in accordance with 21 CFR 1308.23(e). Electronic comments must be submitted, and written comments must be postmarked, on or before October 31, 2022. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. eastern time on the last day of the comment period.
ADDRESSES:
To ensure proper handling of comments, please reference “Docket No. DEA-372” on all correspondence, including any attachments.
Electronic comments:
DEA encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or to attach a file for lengthier comments. Please go to
http://www.regulations.gov
and follow the online instructions at that site for submitting comments. Upon completion of your submission you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on
Regulations.gov.
If you have received a comment tracking number, your comment has been successfully submitted and there is no need to resubmit the same comment.
Paper comments:
Paper comments that duplicate the electronic submission are not necessary and are discouraged. Should you wish to mail a comment
in lieu of
an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.
FOR FURTHER INFORMATION CONTACT:
Terrence L. Boos, Ph.D., Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362-8201.
SUPPLEMENTARY INFORMATION:
Posting of Public Comments
Please note that all comments received are considered part of the public record and made available for public inspection online at
http://
( printed page 53495)
www.regulations.gov
and in the DEA's public docket. Such information includes personal identifying information (such as your name, address, etc.) voluntarily submitted by the commenter. The Freedom of Information Act applies to all comments received.
If you want to submit personal identifying information (such as your name, address, etc.) as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “PERSONAL IDENTIFYING INFORMATION” in the first paragraph of your comment. You must also place all the personal identifying information you do not want posted online or made available in the public docket in the first paragraph of your comment and identify what information you want redacted.
If you want to submit confidential business information as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “CONFIDENTIAL BUSINESS INFORMATION” in the first paragraph of your comment. You must also prominently identify confidential business information to be redacted within the comment.
Comments containing personal identifying information and confidential business information identified as directed above will generally be made publicly available in redacted form. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be made publicly available. Comments posted to
http://www.regulations.gov
may include any personal identifying information (such as name, address, and phone number) included in the text of your electronic submission that is not identified as directed above as confidential.
Section 201 of the Controlled Substances Act (CSA) (21 U.S.C. 811) authorizes the Attorney General, by regulation, to exempt from certain provisions of the CSA certain compounds, mixtures, or preparations containing a controlled substance, if he finds that such compounds, mixtures, or preparations meet the requirements detailed in 21 U.S.C. 811(g)(3)(B).[1]
The Drug Enforcement Administration (DEA) regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria by which the DEA Assistant Administrator may exempt a chemical preparation or mixture from certain provisions of the CSA. The Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by which exemptions are granted and modify the scope of exemptions at any time.
Exempt Chemical Preparation Applications Submitted Between August 30, 2021, and March 31, 2022
DEA received applications between August 30, 2021, and March 31, 2022, requesting exempt chemical preparation status detailed in 21 CFR 1308.23. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart I below is intended for laboratory, industrial, educational, or special research purposes and not for general administration to a human being or animal and either: (1) contains no narcotic controlled substance and is packaged in such a form or concentration that the packaged quantity does not present any significant potential for abuse; or (2) contains either a narcotic or non-narcotic controlled substance and one or more adulterating or denaturing agents in such a manner, combination, quantity, proportion, or concentration that the preparation or mixture does not present any potential for abuse and, if the preparation or mixture contains a narcotic controlled substance, is formulated in such a manner that it incorporates methods of denaturing or other means so that the preparation or mixture is not liable to be abused or have ill effects, if abused, and so that the narcotic substance cannot in practice be removed.
Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, and 21 CFR 1308.24, the Assistant Administrator has determined that each of the chemical preparations or mixtures generally described in Chart I below and specifically described in the application materials received by DEA is exempt, to the extent described in 21 CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of the CSA, and 21 CFR 1301.74, as of the date that was provided in the approval letters to the individual requesters.
Scope of Approval
The exemptions are applicable only to the precise preparation or mixture described in the application submitted to DEA in the form(s) listed in this order and only for those above mentioned sections of the CSA and the CFR. In accordance with 21 CFR 1308.24(h), any change in the quantitative or qualitative composition of the preparation or mixture, or change in the trade name or other designation of the preparation or mixture after the date of application requires a new application. The requirements set forth in 21 CFR 1308.24(b)-(e) apply to the exempted materials. In accordance with 21 CFR 1308.24(g), DEA may prescribe requirements other than those set forth in 21 CFR 1308.24(b)-(e) on a case-by-case basis for materials exempted in bulk quantities. Accordingly, in order to limit opportunity for diversion from the larger bulk quantities, DEA has determined that each of the exempted bulk products listed in this order may only be used in-house by the manufacturer, and may not be distributed for any purpose, or transported to other facilities.
Additional exempt chemical preparation requests received between August 30, 2021, and March 31, 2022, and not otherwise referenced in this order, may remain under consideration until DEA receives additional information required, pursuant to 21 CFR 1308.23(d), as detailed in separate correspondence to individual requesters. DEA's order on such requests will be communicated to the public in a future
Federal Register
publication.
DEA also notes that these exemptions are limited to exemption from only those sections of the CSA and the CFR that are specifically identified in 21 CFR 1308.24(a). All other requirements of the CSA and the CFR apply, including registration as an importer as required by 21 U.S.C. 957.
( printed page 53496)
Chart I
Supplier
Product name
Form
Application
date
Aalto Scientific, Ltd
Unassayed Chemistry Base Level 1
Glass or plastic bottle or flask: 1mL-100 mL; 100mL-500mL; 500mL-1L
3/28/2022
Aalto Scientific, Ltd
Unassayed Chemistry Base Level 2
Glass or plastic bottle or flask: 1mL-100 mL; 100mL-500mL; 500mL-1L
3/28/2022
Aalto Scientific, Ltd
Unassayed Chemistry Base Level 3
Glass or plastic bottle or flask: 1mL-100 mL; 100mL-500mL; 500mL-1L
3/28/2022
Absolute Standards, Inc
(-)-Δ8-THC-D3, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
(-)-Δ9-THC-D3, 100 ug/mL, in Ethanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
(-)-Δ9-THC-D3, 1000 ug/mL, in Ethanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
(+/-)-11-Hydroxy-Δ9-THC-D3, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
(+/-)-11-Hydroxy-Δ9-THC-D3, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
(+/-)-Amphetamine-D8, 10 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
(+/-)-Amphetamine-D8, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
(+/-)-Amphetamine-D8, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
(+/-)-Methamphetamine-D8, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
(+/-)-Methamphetamine-D8, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
(+/-)-Methamphetamine-D9, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
AB-CHMINACA, 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
AB-FUBINACA, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
AB-PINACA, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
AH-7921, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
AKB48 (APINACA), 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
alpha-Pyrrolidinobutiophenone (alpha-PBP), 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
AM2201, 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
AM2201, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Benzoylecgonine, 10 ug/ml, in Methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Benzoylecgonine, 100 ug/ml, in Methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Benzoylecgonine, 1000 ug/ml, in Methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Benzoylecgonine-D8, 100 ug/ml, in Methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Benzoylecgonine-D8, 1000 ug/ml, in Methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Cocaine-D3, 10 ug/ml, in Methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Cocaine-D3, 100 ug/ml, in Methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Cocaine-D3, 1000 ug/ml, in Methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Codeine-6-β-glucuronide, 10 ug/ml, in acetonitrile:water [1:1]
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Codeine-6-β-glucuronide, 100 ug/ml, in acetonitrile:water [1:1]
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Codeine-6-β-glucuronide, 1000 ug/ml, in acetonitrile:water [1:1]
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
d,l-MDEA, 10 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
d,l-MDEA, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
d,l-MDEA, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
d,l-Methadone, 10 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
d,l-Methadone, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
d,l-Methadone, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
d,l-Methadone-D3, 10 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
d,l-Methadone-D3, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
d,l-Methadone-D3, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
DBP Mix, 100 ug/ml, in MTBE
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
DBP Mix, 100 ug/ml, in MTBE
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Dimethyltryptamine, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Dimethyltryptamine, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
d-Propoxyphene, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
d-Propoxyphene, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Ecognine methyl ester, 10 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Ecognine methyl ester, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Ecognine methyl ester, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
EPA Method 551 “Mix B”, 1000 ug/ml, in MTBE
Glass ampoule: 1 ml x 5
1/10/2022
Absolute Standards, Inc
EPA Method 551—Disinfection By-Products Mix #2, 100 ug/ml, in MTBE
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
EPA Method 551.1—Analytes Mix #2, 100 ug/ml, in MTBE
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Fenproporex, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
( printed page 53497)
Absolute Standards, Inc
Fenproporex-D5, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
FUB-144, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
FUB-AKB48 (FUB-APINACA), 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Heroin-D9, 10 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Heroin-D9, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Heroin-D9, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Hydrocodone (+)-bitartrate salt, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Hydrocodone (+)-bitartrate salt, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Hydrocodone, 10 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Hydrocodone, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Hydrocodone, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Hydromorphone, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Hydromorphone, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
JWH-019, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
JWH-073, 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
JWH-073, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
JWH-081, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
JWH-122, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
JWH-200, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
JWH-200-d5, 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
JWH-250, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Ketamine, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Ketamine, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Ketamine-D4, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Lysergic acid diethylamide (LSD), 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Lysergic acid diethylamide (LSD), 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Lysergic acid diethylamide (LSD), 1000 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Lysergic acid diethylamide (LSD), 1000 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Meperidine, 10 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Meperidine, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Meperidine, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Mephedrone, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Mephedrone, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Mix A, 1000 ug/ml, in MTBE
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
MMB-FUBINACA, 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
MMB-FUBINACA, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Nitrazepam, 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Nitrazepam, 1000 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
NM2201, 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Oxazepam, 10 ug/ml, in acetonitrile
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Oxazepam, 10 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Oxazepam, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Oxazepam, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Oxycodone, 10 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Oxycodone, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Oxycodone, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Oxycodone-D3, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Oxycodone-D3, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Oxycodone-D6, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Oxycodone-D6, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Oxymorphone, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Oxymorphone, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Oxymorphone-D3, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Oxymorphone-D3, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
PB-22, 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Phencyclidine-D5, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Phencyclidine-D5, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Phenylacetone, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Pregabalin, 10 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Pregabalin, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Pregabalin, 1000 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Psilocin, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Psilocin, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Psilocybin PT, varied ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
RCS-4, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
( printed page 53498)
Absolute Standards, Inc
THC-O-acetate, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
THC-O-acetate, 1000 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
THC-O-acetate, varied ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Tramadol, 10 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
Tramadol, 100 ug/ml, in methanol
Glass ampoule: 1 ml
1/10/2022
Absolute Standards, Inc
UR-144, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
XLR-11, 100 ug/mL, in Methanol
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Zopiclone, 100 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Absolute Standards, Inc
Zopiclone, 1000 ug/mL, in Acetonitrile
Glass ampoule: 1 mL
2/14/2022
Audit MicroControls, Inc
Control FLQ Unassayed Chemistry, Level 1
Kit: 10 bottles, 4 mL each
3/30/2022
Audit MicroControls, Inc
Control FLQ Unassayed Chemistry, Level 1
Kit: 5 bottles, 4 mL each
3/30/2022
Audit MicroControls, Inc
Control FLQ Unassayed Chemistry, Level 1
Plastic bottle: 4mL
3/30/2022
Cerilliant Corporation
(6aR,9R)-delta10-THC
Glass ampule: 1.0 mL
8/30/2021
Cerilliant Corporation
5 Part Potency in Beverage
Glass ampule: 1.0 mL
2/22/2022
Cerilliant Corporation
6 Part Potency in Solution (Acids)
Glass ampule: 1.0 mL
1/11/2022
Cerilliant Corporation
8 Part Potency in Solution (Neutrals)
Glass ampule: 1.0 mL
1/11/2022
Chemtos, LLC
(S)-N,N-dimethylamphetamine HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
(S)-N,N-dimethylamphetamine-d3 HCl (0.1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
(S)-N,N-dimethylamphetamine-d3 HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
2,4-DMMC HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
3,4-DMMC HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
3-MMC HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
4-Cl-PVP HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
4-Methylbuphedrone (4-Me-MABP) HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
5F-MDMB-PICA (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
AB-CHMINACA (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
AB-PINACA (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
alpha-PHP HBr (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Alphaprodine HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Alphaprodine-d5 HCl (0.1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Alphaprodine-d5 HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
AM-694 (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Anileridine HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
APINACA, AKB48 (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
bk-MDDMA HCl (Dimethylone) (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Diethyltryptamine (DET) (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Dimethyltryptamine (DMT) (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Dimethyltryptamine-d3 (DMT-d3) (0.1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Dimethyltryptamine-d3 (DMT-d3) (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Dipentylone HCl (bk-DMBDP) (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Estazolam (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Estazolam-d5 (0.1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Estazolam-d5 (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Flunitrazepam (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Flunitrazepam-d3 (0.1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Flunitrazepam-d3 (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Ketamine HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Ketamine-d4 HCl (0.1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Ketamine-d4 HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
MAB-CHMINACA (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
MDMB-CHMICA, MMB-CHMINACA (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
MMB-CHMICA, AMB-CHMICA (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
MPHP HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Naphyrone HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
N-Ethyl-amphetamine HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
N-Ethyl-amphetamine-d5 HCl (0.1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
N-ethylhexedrone (NEH) HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
N-ethylhexedrone-d5 (NEH-d5) HCl (0.1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
NM2201, CBL-2201 (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
PCC (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Phendimetrazine-d8 (0.1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Phendimetrazine-d8 (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
( printed page 53499)
Chemtos, LLC
Phenylacetone (1 mg/mL in acetonitrile)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Propylone HCl (bk-3,4-MDPA) (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
PV8 (PHPP) HCl (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
Tenocyclidine (TCP) (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
Chemtos, LLC
THJ-2201 (AM2201) (1 mg/mL in methanol)
Amber ampule: 1 mL
3/14/2022
CPI International
Custom Hormone Mix, 9-072, 1000 mg/L, 1 mL (ISO 17025)
Amber ampule: 1 mL
2/2/2022
LabSystems Diagnostics
NeoMass CAH Extraction Solution with Internal Standard
NeoMass CAH System suitability Mixture CAH (lyophilized)
Glass vial: 2 mL
1/10/2022
LabSystems Diagnostics
NeoMass CAH Tuning Mixture CAH (lyophilized)
Glass vial: 2 mL
1/10/2022
LGC
Narcotics Mixture 1 0.02-0.075 μg/mL in Synthetic oral fluid
1 kit; 10 × 1 mL amber cryule
3/8/2022
LGC
Narcotics Mixture 2 0.01-0.05 μg/mL in Synthetic oral fluid
1 kit; 10 × 1 mL amber cryule
3/8/2022
LGC
Narcotics Mixture 3 0.001-0.01 μg/mL in Synthetic oral fluid
1 kit; 10 × 1 mL amber cryule
3/8/2022
LGC—Dr. Ehrenstorfer
(6aR,9R)-Δ10-Tetrahydrocannabinol 100 μg/mL in Methanol
Amber Ampule: 1 mL
12/21/2021
LGC—Dr. Ehrenstorfer
(6aR-trans)-Δ8-Tetrahydrocannabinol acetate 100 μg/mL in Methanol
Amber Ampule: 1 mL
12/21/2021
LGC—Dr. Ehrenstorfer
Custom Cannabinoid Mixture 10141 1000 ug/mL in Acetonitrile
Amber ampule: 1 mL
3/4/2022
LGC—Dr. Ehrenstorfer
Custom Cannabinoid Mixture 10142 1000 ug/mL in Acetonitrile
1 kit; 5 × 1 mL amber ampule
3/4/2022
LGC—Dr. Ehrenstorfer
Custom Pharmaceutical Mixture 10147 1000 ug/mL in Acetonitrile
Amber ampule: 1 mL
3/4/2022
LGC—Dr. Ehrenstorfer
Custom Pharmaceutical Mixture 10148 1000 ug/mL in Acetonitrile
1 kit; 5 × 1 mL amber ampule
3/4/2022
LGC—Dr. Ehrenstorfer
Custom Tramadol hydrochloride 100 μg/mL in Methanol
Glass Ampule: 1 mL
1/27/2022
LGC—Dr. Ehrenstorfer
Trenbolone cyclohexylmethylcarbonate 100 μg/mL in Acetonitrile
Amber Ampule: 1 mL
12/21/2021
LGC—Dr. Ehrenstorfer
Zolpidem tartrate 100 μg/mL in Methanol
Glass Ampule: 1 mL
1/27/2022
LGC Clinical Diagnostics, Inc
Fertility 1 ab Bulk—Level 1
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 ab Bulk—Level 2
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 ab Bulk—Level 3
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 ab Bulk—Level 4
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 ab Bulk—Level 5
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 ab WrkBlk—Level 1
Volumetric flask: 200-8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 ab WrkBlk—Level 5
Volumetric flask: 200-8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 re Bulk—Level 1
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 re Bulk—Level 2
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 re Bulk—Level 3
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 re Bulk—Level 4
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 re Bulk—Level 5
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 re WrkBlk—Level 1
Volumetric flask: 200-8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Fertility 1 re WrkBlk—Level 5
Volumetric flask: 200-8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ab Bulk—Level 1
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ab Bulk—Level 2
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ab Bulk—Level 3
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ab Bulk—Level 4
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ab Bulk—Level 5
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ab WrkBlk—Level 1
Volumetric flask: 200-8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 au Bulk—Level 1
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 au Bulk—Level 2
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 au Bulk—Level 3
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 au Bulk—Level 4
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 au Bulk—Level 5
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 au WrkBlk—Level 1
Volumetric flask: 200-8000 mL
3/21/2022
( printed page 53500)
LGC Clinical Diagnostics, Inc
TDM1 bc Bulk—Level 1
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 bc Bulk—Level 2
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 bc Bulk—Level 3
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 bc Bulk—Level 4
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 bc Bulk—Level 5
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 bc WrkBlk—Level 1
Volumetric flask: 200-8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 db Bulk—Level 1
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 db Bulk—Level 2
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 db Bulk—Level 3
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 db Bulk—Level 4
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 db Bulk—Level 5
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 db WrkBlk—Level 1
Volumetric flask: 200-8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri GentC Set Bulk—Level 1
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri GentC Set Bulk—Level 2
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri GentC Set Bulk—Level 3
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri GentC Set Bulk—Level 4
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri GentC Set Bulk—Level 5
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri GentC Set WrkBlk—Level 1
Volumetric flask: 200-8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri TDM Set Bulk—Level 1
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri TDM Set Bulk—Level 2
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri TDM Set Bulk—Level 3
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri TDM Set Bulk—Level 4
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri TDM Set Bulk—Level 5
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri TDM Set WrkBlk—Level 1
Volumetric flask: 200-8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 vt Set Bulk—Level 1
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 vt Set Bulk—Level 2
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 vt Set Bulk—Level 3
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 vt Set Bulk—Level 4
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 vt Set Bulk—Level 5
Volumetric flask: 3200 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 vt Set WrkBlk—Level 1
Volumetric flask: 200-8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Testosterone (TSTO) Stock A 100,000 ng/ml
Plastic vial: 25 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Testosterone (TSTO) Stock B 2,000 ng/ml
Plastic vial: 25 mL
3/21/2022
LGC Clinical Diagnostics, Inc
VALIDATE Fertility 1 Test Set 502ab
5 Bottles: 4 mL each
3/21/2022
LGC Clinical Diagnostics, Inc
VALIDATE Fertility 1 Test Set 502re
5 Bottles: 4 mL each
3/21/2022
LGC Clinical Diagnostics, Inc
VALIDATE TDM1 Test Set 301ab
Kit: 5 Bottles, 3 ml each
3/21/2022
LGC Clinical Diagnostics, Inc
VALIDATE TDM1 Test Set 301au
Kit: 5 Bottles, 3 ml each
3/21/2022
LGC Clinical Diagnostics, Inc
VALIDATE TDM1 Test Set 301bc
Kit: 5 Bottles, 3 ml each
3/21/2022
LGC Clinical Diagnostics, Inc
VALIDATE TDM1 Test Set 301db
Kit: 5 Bottles, 3 ml each
3/21/2022
LGC Clinical Diagnostics, Inc
VALIDATE TDM1 Test Set 301ri
Kit: 5 Bottles, 3 ml each; 5 bottles, 2 mL each
3/21/2022
LGC Clinical Diagnostics, Inc
VALIDATE TDM1 Test Set 301vt
Kit: 5 Bottles, 3 ml each
3/21/2022
o2si smart solutions
Custom Pharmaceutical Mixture, 12-0370, 100 ug/mL, 5 × 1 mL (ISO 17034)
1 Package; 5 × 1 mL amber ampules
1/14/2022
o2si smart solutions
Hydrocodone hydrogen (+)-bitartrate as hydrocodone in acetonitrile Solution, 5,000 mg/L PARENT STOCK SOLUTION—NOT FOR SALE
Amber ampule: 1 mL
2/11/2022
Restek Corporation
Custom Heroin Standard
Glass ampule: 1.3 mL
3/8/2022
RTI International
12198-62-06
Glass tube: 7 mL
3/1/2022
RTI International
2023 DMPM-01
HDPE Bottle: 40 mL
3/30/2022
RTI International
2023 DMPM-02
HDPE Bottle: 40 mL
3/30/2022
RTI International
2023 DMPM-03
HDPE Bottle: 40 mL
3/30/2022
RTI International
2023 DMPM-05
HDPE Bottle: 40 mL
3/30/2022
RTI International
2023 DMPM-06
HDPE Bottle: 40 mL
3/30/2022
RTI International
2023 DMPM-07
HDPE Bottle: 40 mL
3/30/2022
RTI International
2023 FTC-02
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 FTC-03
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 FTC-05
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 FTC-06
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 FTC-07
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 FTC-09
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 FTC-10
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 FTC-11
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 FTC-13
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 FTC-14
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 FTC-15
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 OFD-01
Vial: 2 mL
3/30/2022
( printed page 53501)
RTI International
2023 OFD-02
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-03
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-04
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-05
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-06
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-07
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-08
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-10
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-11
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-12
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-13
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-14
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-15
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-16
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-17
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-18
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-19
Vial: 2 mL
3/30/2022
RTI International
2023 OFD-20
Vial: 2 mL
3/30/2022
RTI International
2023 T-02
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 T-03
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 T-04
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 T-05
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 T-06
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 T-07
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 T-08
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 T-11
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 T-12
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 T-14
HDPE Bottle: 20 mL
3/30/2022
RTI International
2023 THCB-01
Vial: 10 mL
3/30/2022
RTI International
2023 THCB-02
Vial: 10 mL
3/30/2022
RTI International
2023 THCB-03
Vial: 10 mL
3/30/2022
RTI International
2023 THCB-04
Vial: 10 mL
3/30/2022
RTI International
2023 THCB-05
Vial: 10 mL
3/30/2022
RTI International
2023 THCB-06
Vial: 10 mL
3/30/2022
RTI International
2023 UDS-01
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-02
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-03
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-04
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-05
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-06
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-07
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-08
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-09
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-10
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-11
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-12
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-13
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-14
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UDS-15
HDPE Bottle: 10 mL
3/30/2022
RTI International
2023 UT-01
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-02
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-03
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-05
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-06
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-07
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-08
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-09
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-10
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-11
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-12
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-13
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-14
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UT-15
HDPE Bottle: 50 mL
3/30/2022
RTI International
2023 UTCO-01
HDPE Bottle: 40 mL
3/30/2022
RTI International
2023 ZE-01
Vial: 5 mL
3/30/2022
RTI International
2023 ZE-02
Vial: 5 mL
3/30/2022
RTI International
2023 ZE-03
Vial: 5 mL
3/30/2022
RTI International
2023 ZE-04
Vial: 5 mL
3/30/2022
RTI International
2023 ZE-05
Vial: 5 mL
3/30/2022
RTI International
2023 ZE-06
Vial: 5 mL
3/30/2022
RTI International
2023-OFD-09
Vial: 2 mL
3/30/2022
( printed page 53502)
RTI International
Sample 1 Matrix: Urine
HDPE tubes: 5 mL
3/7/2022
RTI International
Sample 2 Matrix: Urine
HDPE tubes: 5 mL
3/7/2022
RTI International
Sample 3 Matrix: Plasma
HDPE tubes: 5 mL
3/7/2022
RTI International
Sample 4 Matrix: Urine
HDPE tubes: 5 mL
3/7/2022
RTI International
Sample 6 Matrix: Whole Blood
HDPE tubes: 5 mL
3/7/2022
Thermo Fisher Scientific
Cascadion SM Antiepileptics Internal Standard
Box: 6 vials, 29 mL each
3/24/2022
The Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart II below is not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23. Accordingly, the Assistant Administrator has determined that the chemical preparations or mixtures generally described in Chart II below and specifically described in the application materials received by DEA, are not exempt from application of any part of the CSA or from application of any part of the CFR, with regard to the requested exemption pursuant to 21 CFR 1308.23, as of the date that was provided in the determination letters to the individual requesters.
Chart II
Supplier
Product name
Form
Application
date
Chemtos, LLC
ANPP (1 mg/mL in acetonitrile)
Amber ampule: 1mL
3/14/2022
CPI International
Custom Hormone Mix, 9-072, 1000 mg/L, 6 x 1 ml
1 Package; 6 x 1 mL amber ampules
1/14/2022
LGC Clinical Diagnostics, Inc
TDM1 ab WrkBlk—Level 5
Volumetric flask: 200—8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 au WrkBlk—Level 5
Volumetric flask: 200—8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 bc WrkBlk—Level 5
Volumetric flask: 200—8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 db WrkBlk—Level 5
Volumetric flask: 200—8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri GentC Set WrkBlk—Level 5
Volumetric flask: 200—8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 ri TDM Set WrkBlk—Level 5
Volumetric flask: 200—8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
TDM1 vt Set WrkBlk—Level 5
Volumetric flask: 200—8000 mL
3/21/2022
LGC Clinical Diagnostics, Inc
Validate TDM Phenobarbital Stock
Plastic vial: 150 mL
3/21/2022
Opportunity for Comment
Pursuant to 21 CFR 1308.23(e), any interested person may submit written comments on or objections to any chemical preparation in this order that has been approved or denied as exempt. If any comments or objections raise significant issues regarding any finding of fact or conclusion of law upon which this order is based, the Assistant Administrator will immediately suspend the effectiveness of any applicable part of this order until she may reconsider the application in light of the comments and objections filed. Thereafter, the Assistant Administrator shall reinstate, revoke, or amend his original order as she determines appropriate.
Approved Exempt Chemical Preparations are Posted on the DEA's Website
1.
This authority has been delegated from the Attorney General to the DEA Administrator by 28 CFR 0.100, and subsequently redelegated to the Deputy Assistant Administrator pursuant to 28 CFR 0.104 and section 7 of the appendix to subpart R of part 0.
Use this for formal legal and research references to the published document.
87 FR 53494
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Exempt Chemical Preparations Under the Controlled Substances Act,” thefederalregister.org (August 31, 2022), https://thefederalregister.org/documents/2022-18794/exempt-chemical-preparations-under-the-controlled-substances-act.